Trials / Not Yet Recruiting
Not Yet RecruitingNCT07139912
Prospective, Multicenter, Single-Arm Study of Aortic Arch Pathology Reconstruction
Prospective, Multicenter, Single-Arm Trial Assessing Safety/Effectiveness of Multi-Branch Thoracic Stent Grafts in Aortic Arch Disease
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A prospective ,multiple center Study about the Safety and Efficacy of the Thoracic Aortic Multi-Branch Stent Graft System, developed and manufactured by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., in patients with aortic arch pathologies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Thoracic Aortic Multi-Branch Stent Graft System | The Thoracic Aortic Multi-Branch Stent Graft Systemm consists of the Single-Branch Aortic Stent-Graft System, the aortic extension stent graft system and the branch stent system. |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2028-03-01
- Completion
- 2032-03-01
- First posted
- 2025-08-24
- Last updated
- 2025-08-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07139912. Inclusion in this directory is not an endorsement.